Yeghig Armoudjian obtained his Master degree in Chemical technologies in Armenia. Since 2014, Yeghig ambitiously worked to develop and validate more than fourteen bioanalytical methods (in accordance with FDA and EMA guidelines), for the determination of pharmaceuticals in human plasma using UHPLC - MS/MS. These methods were applied to analyse clinical samples for pharmacokinetic and pharmacodynamic studies. Yeghig's chemistry background and his determined work in the laboratory resulted in faster and more robust sample preparation techniques. Yeghig gained extensive troubleshooting skills while working with Sciex TQ MS/MSs, as well as Agilent and Shimadzu UHPLCs: these highly sensitive instruments need abundant care, to ensure continuous system performance, while obtaining reliable data and safeguarding instrument longevity. While working in a regulated environment, Yeghig adhered to the principles of GLP in all his laboratory activities. Some of Yeghig's activities have been published in highly ranked scientific journals.

Qi Lin achieved her PhD in Pharmaceutical Sciences at KU Leuven in 2019. Her expertise in LC method development and validation devotes to solve challenges on separation in the LC analysis of complex pharmaceutical substances (i.e. biosynthesized antibiotics or structurally similar compounds) or complex mixtures (i.e. drug product, tablets, injections, etc.). She has previously worked as an external research member for European Directorate for the Quality of Medicines (EDQM) in 2015 – 2019, as part of the PhD job responsibilities. Three LC methods were successfully developed and validated for the individual analysis of spiramycin, tylosin and apramycin, to separate and detect the API and >30 structurally related impurities. Meanwhile, several unknown impurities of three antibiotics were also characterized using LC-MS/MS for the first time. These LC methods have been reviewing by EDQM in order to be enrolled as standards in the European Pharmacopoeia. Since 2014, she has also worked for projects outsourced by UZ Leuven and pharmaceutical manufacturers, containing the analysis of different pharmaceutical products (tablets, injection, suspension and infusion) and API (prostaglandin, papaverine, sufentanil, ropivacaine, chirocaine, lincomycin, vancomycin, polymyxin and tobramycin) including method development and validation, assay, European Pharmacopoeial test and stability study. More than 20 projects have been completed with a high quality to the satisfaction of customers.

Rodolfo Hernandes Bonan obtained his Master degree in Civil Engineering in Brazil. Since 2019 Rodolfo started developing scripts and tools using R and Python focused in statistical analysis and data visualization. Experience in the Pharmacometrics field using softwares like PK-Sim/MoBi (Open systems pharmacology®) and Monolix Suite (Lixoft®).